18PDissecting the antitumor immune response upon PARP inhibition in homologous recombination repair (HRR)-deficient tumors. (17th December 2018) - Pellegrino, B; Llop-Guevara, A; Cruz, C; Castroviejo, M; Cedro-Tanda, A; Fasani, R; Nuciforo, P G; Gros, A; Balmaña, J; O'Connor, M J; Serra Elizalde, V